COMMUNIQUÉS West-GlobeNewswire

ESPERITE (ESP) expects publication of Annual Report 2017 before 18 June 2018
05/06/2018
Amsterdam, The Netherlands - 05 June 2018 Esperite regrets to announce that due to the technical issues as reported on 30 April and despite the constant efforts provided by the different teams involved, additional time [...]
Basilea reports presentation of phase 1 clinical data with anticancer drug candidate BAL101553 at ASCO meeting
05/06/2018
Data support expansion into phase 2a Basel, Switzerland, June 05, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that data from the phase 1 dose-escalation parts of two phase 1/2a studies with weekly 48- [...]
Kiadis Pharma announces results of Annual General Meeting
05/06/2018
Kiadis Pharma announces results of Annual General Meeting Amsterdam, The Netherlands, June 5, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical stage [...]
FibroGen to Present at Two Upcoming Investor Conferences
04/06/2018
SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company, today announced that management will participate in a Fireside Chat at the Jefferies 2018 Healthcare Conference [...]
Kalytera Announces Next Monthly Payment in Shares under Services Agreement with Salzman Group
04/06/2018
SAN FRANCISCO and TEL AVIV, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to issue [...]
RadNet, Inc. to Present at the 8th Annual LD Micro Invitational on June 6th
05/06/2018
LOS ANGELES, June 04, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
TESARO Summarizes TOPACIO and QUADRA Trial Results Presented at 2018 ASCO Annual Meeting
05/06/2018
TOPACIO data for ZEJULA ® (niraparib) in combination with an anti-PD-1 mAb highlight promising activity in platinum-resistant/refractory ovarian cancer and triple-negative breast cancer beyond patients with BRCA [...]
Public Health Laboratory Leaders Honored by APHL
04/06/2018
Silver Spring, MD, June 04, 2018 (GLOBE NEWSWIRE) -- The Association of Public Health Laboratories (APHL) is pleased to announce the winners of its annual awards for outstanding achievements in laboratory science, [...]
Cannabis Wheaton Announces Results From the Annual and Special Meeting
04/06/2018
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to announce the results of voting at its annual and special [...]
Optinose Announces Launch of Public Offering of Common Stock
04/06/2018
YARDLEY, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) and commenced a [...]
Molecular Templates Presents Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
04/06/2018
ASCO Posters Feature Data on MT-3724 and Evofosfamide AUSTIN, Texas, June 04, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM), a clinical stage biopharmaceutical company focused on the discovery and [...]
OrthoPediatrics Corp. Announces First Surgery Performed with Pediatric Nailing Platform | FEMUR
04/06/2018
WARSAW, Ind., June 04, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the first surgery [...]
Osiris Announces Implementation of Prestige Lyotechnology℠ Preservation Method Allowing Ambient Storage of Living Tissues
04/06/2018
COLUMBIA, Md., June 04, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Amedisys to Repurchase 50% of Shares Held by KKR
04/06/2018
Accretive Transaction to Reduce Outstanding Shares by 2.4 Million or 7.1% KKR to Maintain its Board Seat For at Least Twelve Months Following the Transaction BATON ROUGE, La., June 04, 2018 (GLOBE NEWSWIRE) -- Amedisys [...]
Portola Pharmaceuticals Announces Retirement of CEO Bill Lis in 2018
04/06/2018
SOUTH SAN FRANCISCO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that William Lis has informed the Board of Directors of his plans to retire as Chief Executive [...]
INSYS Therapeutics to Present at Jefferies Global Healthcare Conference
04/06/2018
PHOENIX, June 04, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that [...]
HealthEquity Reports First Quarter Ended April 30, 2018 Financial Results
04/06/2018
Highlights of the first quarter include: Revenue of $69.9 million, an increase of 26% compared to Q1 FY18. Net income of $22.6 million, an increase of 61% compared to Q1 FY18. Net income per diluted share of $0.36 [...]
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018
04/06/2018
RANCHO CUCAMONGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June [...]
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/06/2018
WAYNE, Pa., June 04, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated [...]

Pages